Formulation and in vitro evaluation of a siRNA delivery nanosystem decorated with gH625 peptide for triple negative breast cancer theranosis

Sanaa Ben Djemaa; Stephanie David; Katel Hervé-Aubert; Annarita Falanga; Stefania Galdiero; Émilie Allard-Vannier; Igor Chourpa; Emilie Munnier

doi:10.1016/j.ejpb.2018.07.024

Journal articles

Formulation and in vitro evaluation of a siRNA delivery nanosystem decorated with gH625 peptide for triple negative breast cancer theranosis

Sanaa Ben Djemaa ¹ Stephanie David ^{1, *} Katel Hervé-Aubert ¹ Annarita Falanga ² Stefania Galdiero ³ Émilie Allard-Vannier ¹ Igor Chourpa ¹ Emilie Munnier ¹

* Corresponding author

1 NMNS - Nanomédicaments et Nanosondes, EA 6295

2 Department of Pharmacy and CIRPeB

3 Department of Pharmacy and CIRPeB

Document type :

Journal articles

Domain :

Life Sciences [q-bio] / Biochemistry, Molecular Biology

Life Sciences [q-bio] / Cancer

Life Sciences [q-bio] / Bioengineering

Complete list of metadata

https://hal-univ-tours.archives-ouvertes.fr/hal-01919906
Contributor : Martin Soucé Connect in order to contact the contributor
Submitted on : Monday, November 12, 2018 - 5:58:36 PM
Last modification on : Thursday, March 10, 2022 - 6:52:02 PM

Formulation and in vitro evaluation of a siRNA delivery nanosystem decorated with gH625 peptide for triple negative breast cancer theranosis

Links full text

Identifiers

Collections

Citation

Export

Metrics

51

Formulation and in vitro evaluation of a siRNA delivery nanosystem decorated with gH625 peptide for triple negative breast cancer theranosis

Links full text

Identifiers

Collections

Citation

Export

Share

Metrics

51